HEART FAILURE

This trial asks whether people with heart failure who take SGLT-2 inhibitors (like dapagliflozin or empagliflozin) should continue the medication right up to cardiac surgery, rather than stopping it three days before as currently recommended. The study will compare outcomes like …

This early-stage trial will test a single dose of a new drug called LY3971297 in 90 people with two types of heart failure: preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). The main goal is to see if the drug is safe and what side effects occur. Particip…

This study tests a device called TricValve for people with severe tricuspid regurgitation, a condition where a heart valve leaks. The device is implanted in the veins to help blood flow better. About 780 participants will be randomly assigned to get the device plus standard medic…

This phase 3 trial investigates whether adding acetazolamide—a drug often used for altitude sickness—to standard diuretics can improve fluid removal in people with heart failure who experience sudden fluid buildup. Participants take the medication for up to five days while being …

This trial investigates whether a high-protein diet, with or without an HMB supplement, can improve muscle mass, strength, and physical function in people with heart failure. Participants are randomly assigned to one of three groups: a standard-protein diet, a high-protein diet, …

This trial tests whether a nurse-led education program can improve self-care knowledge in people with heart failure in Rwanda. About 400 participants from three district hospitals will receive illustrated flip-book teaching and a simplified handout. The study measures changes in …

This study tests whether using a real-time continuous glucose monitor (CGM) can improve blood sugar control and reduce hospital readmissions in people with type 2 diabetes and acute heart failure. Researchers will follow 140 adults during their hospital stay and for three months …

This study tests whether a virtual team of clinical pharmacists and cardiologists can help doctors prescribe the right heart failure medications for Veterans. Many patients do not receive all recommended drugs at effective doses after a hospital stay. The team reviews patient rec…

This study tests whether a nurse-led discharge education program helps heart failure patients avoid unplanned hospital readmissions within 30 days. The program includes an educational assessment, a discharge session using the teach-back method, and a follow-up phone call. Researc…

This study tests whether adding a small amount of saltwater (hypertonic saline) to a standard water pill (furosemide) can help people with heart failure and kidney disease. The goal is to improve fluid removal, reduce hospital readmissions, and lower the risk of death. The trial …

This study compares two pacing methods in 80 people with heart failure and a specific heart block. One method uses a lead placed in the left bundle branch area; the other adds a second lead in the left ventricle. Each participant will try both methods for six months to see which …

This study tests a four-month digital program designed to help people with chronic heart failure take their medications as prescribed. The program includes personalized planning, motivational counseling, and symptom tracking. Researchers will enroll 870 adults in Pakistan who hav…

This platform trial will enroll 1,000 adults with heart failure to test several different treatments at the same time. Participants are randomly assigned to either an experimental intervention or standard care. The main goal is to see if these treatments can prevent death or hosp…

This study tests a wearable device that tracks heart rate, breathing, activity, and fluid buildup in people recently hospitalized for heart failure. 800 participants will either get standard care or standard care plus the device for 90 days. The goal is to see if early alerts fro…

This study tests whether metformin, a standard diabetes medicine, can improve heart function in people who have received a mechanical heart pump (LVAD) for severe heart failure. Researchers will give metformin or a placebo to 108 patients for 12 months and check heart function, b…

This pilot study tests whether heart failure patients whose heart function has returned to normal can safely stop taking two medications (sacubitril/valsartan and dapagliflozin or empagliflozin). Eighty adults whose heart failure was caused by a treatable condition like a heart v…

This study tests whether using detailed PET-CT scans to guide where a pacemaker lead is placed can improve heart function in 20 people with heart failure. Participants will receive a standard pacemaker, but the lead position will be chosen based on scan data. The goal is to see i…

This study tests whether measuring sodium in urine can help doctors give the right amount of diuretics (water pills) to people hospitalized with worsening heart failure. About 260 adults will be split into two groups: one gets standard care, the other gets treatment guided by uri…

This study tests whether a wearable monitoring system (ECG patch, temperature patch, and pulse oximeter) can reduce major heart complications in hospitalized patients with heart disease. About 1500 adults will be monitored either with standard care (vital signs every 4-8 hours) o…

This study tests whether a structured heart-health program can improve heart outcomes in 800 cancer survivors who have heart problems or high heart risk. The program includes exercise, nutrition advice, stress support, and risk-factor management over 12 months. Researchers will c…

This study compares two types of pacemaker procedures in adults with heart failure and atrial fibrillation who are not candidates for rhythm control. All participants will receive a heart ablation, then be randomly assigned to either conduction system pacing or standard cardiac r…

This study compares two drugs, finerenone and spironolactone, in 60 adults with heart failure and diabetic kidney disease who are at high risk for high potassium levels (hyperkalemia). Participants will receive either finerenone daily or spironolactone every other day, plus stand…

This study tests whether the drug finerenone can reduce scarring in the heart muscle and improve heart structure and function in people with heart failure. About 104 adults with mild to moderate heart failure will receive either finerenone or a placebo for 6 months. The main goal…

This study tests a program called Moxie that sends weekly mail and a mobile app to help people with chronic heart, kidney, or diabetes conditions manage their health after a hospital stay. The goal is to see if it reduces the chance of going back to the hospital. About 9000 adult…

This study tests whether a potassium binder called Sodium Zirconium Cyclosilicate can help heart failure patients take higher, more effective doses of a standard medication (aldosterone receptor antagonist) without dangerous potassium spikes. About 110 adults over 70 with heart f…

This study tests whether creating a small opening between the upper heart chambers during mitral valve repair can prevent heart failure symptoms after surgery. Researchers will compare 50 patients who get the extra opening to those who have standard surgery alone. The goal is to …

This study tests whether people hospitalized for acute heart failure can be discharged early and continue treatment at home using a subcutaneous injection of furosemide (a diuretic) instead of staying in the hospital for standard IV diuretics. About 250 adults will be randomly as…

This pilot study will test a clinic that treats both heart failure and methamphetamine use disorder at the same time. Fifty adults with heart failure and active meth use will receive counseling, incentives for staying clean, and optional addiction medications, plus standard heart…

This study compares a newer pacing method called Left Bundle Branch Area Pacing (LBBAP) with the standard coronary sinus pacing for cardiac resynchronization therapy in 44 adults who have both permanent atrial fibrillation and heart failure. The goal is to see if LBBAP better imp…

This study tests a procedure called renal denervation (RDN) in 20 people with heart failure. Doctors use a thin tube to deliver radiofrequency energy to nerves around the kidney arteries, aiming to reduce stress on the heart. Participants continue their usual heart failure medica…

This study tests whether a special pacing method called Bachmann bundle pacing can prevent new atrial fibrillation (a type of irregular heartbeat) in people with heart failure who already need a pacemaker or defibrillator. About 110 participants will be randomly assigned to recei…

This study tests whether AI-generated messages can help doctors improve medication plans for adults with heart failure. About 500 patients will have their doctors receive brief suggestions before appointments. The goal is to see if more patients get the right medications within 3…

This study tests whether using a heart pump (Impella 5.5) along with standard heart failure medications can help people with severe heart failure and shock recover without needing a heart transplant or permanent artificial heart. About 250 adults with weak hearts (ejection fracti…

This study tests a new method to guide where a pacing lead is placed in the heart's upper chambers during cardiac resynchronization therapy for heart failure. Researchers will use a special catheter to map electrical signals and target a specific area called Bachmann's bundle. Th…

This registry will follow 200 people with severe aortic valve stenosis who receive a non-invasive ultrasound therapy called Valvosoft. The treatment uses focused sound waves to soften calcium buildup on the valve without surgery. Researchers will track safety and effectiveness fo…

This study looks at whether giving lower doses of two blood thinners (argatroban and enoxaparin) to adults on ECMO (a machine that helps the heart and lungs) is safe and works well. The goal is to reduce bleeding and clotting problems. About 200 people with pneumonia or heart fai…

This study tests whether quickly starting and increasing guideline-recommended heart failure medications after hospitalization improves outcomes in women. About 360 women from 13 Italian hospitals will be randomly assigned to either a high-intensity care group (rapid drug optimiz…

This study tests whether a nurse navigator program can reduce hospital readmissions in 300 patients who are having hip or knee replacement and also have conditions like heart failure, COPD, or kidney problems. The program provides education and connects patients with their primar…

This study compares two blood thinners—apixaban (Eliquis) and warfarin (Coumadin)—in 460 people with advanced heart failure who have a HeartMate 3 heart pump. The goal is to see which drug better prevents strokes, pump clots, and serious bleeding. Participants must have had their…

This study tests if a mouthpiece worn during sleep can help people with both heart failure and obstructive sleep apnea. The device keeps the airway open, which may reduce stress on the heart and improve quality of life. 328 participants will use either the real device or a sham o…

This phase 2 trial tests whether adding L-arginine, a natural amino acid, to standard heart failure treatment improves heart function and symptoms. Researchers will enroll 200 stable heart failure patients with low ejection fraction (under 40%). Participants will receive either L…

This study tests whether a national hospital accreditation program for heart failure centers can improve care and outcomes for patients hospitalized with heart failure. About 6,240 adults across multiple hospitals in China will be followed for 12 months after discharge. The progr…

This study tests whether using remote blood pressure monitors and video doctor visits can help people living in rural areas better manage their heart failure. Researchers will enroll 32 adults with heart failure to see if this approach is practical and acceptable. The goal is to …

This early-stage trial tests whether relaxin, a natural hormone given as a daily injection, can reduce the burden of atrial fibrillation (AF) in 208 veterans who have not responded to standard medications and are scheduled for catheter ablation. The study aims to see if relaxin c…

This study tests whether adding finerenone to standard heart failure treatment (an SGLT2 inhibitor) can reduce deaths and hospitalizations. About 60 adults aged 18-65 with newly diagnosed heart failure will be split into two groups: one gets the standard drug alone, the other get…

This early-phase trial will test whether injecting lab-grown heart muscle cells (made from stem cells) into the heart can safely help people with severe heart failure. Fourteen participants with weak hearts will receive the cells via a catheter. The main goal is to check for side…

This study tests a new approach for people with end-stage heart failure and permanent atrial fibrillation who are waiting for a heart transplant or heart pump. Participants will receive either a standard implantable defibrillator (ICD) alone or an ICD plus a special pacing lead a…

This study tests whether the drug finerenone can slow kidney function decline and lower heart failure risk in 120 adults with type 2 diabetes and chronic kidney disease. Participants must already be on standard blood pressure medications. The study will measure changes in kidney …

This study looks at whether reducing the number of kidney function tests during heart failure treatment helps patients reach the best medication doses more safely. About 344 adults with heart failure and reduced ejection fraction will take part. The goal is to improve drug dosing…

This study tests whether using a smartwatch combined with artificial intelligence can improve recovery for people who have had a heart attack. 200 adults aged 18-75 who recently had a heart attack and a stent placed will wear a smartwatch that tracks health data. The AI analyzes …

This phase 3 trial tests whether the drug finerenone (Kerendia) can improve heart structure and function in 156 adults with heart failure and an enlarged left ventricle. Participants take finerenone or a placebo daily for 12 months, alongside standard care. Heart changes are meas…

This study looks at whether roxadustat, a drug for anemia in chronic kidney disease, can also help people with heart failure. Researchers will review medical records of 200 patients who took roxadustat for at least a year. They will check heart function, symptoms, and major event…

This early-stage trial tests a single injection of SHR-4658 in 48 healthy volunteers and people with slightly high blood pressure. The main goal is to check safety and how the body processes the drug. If it passes safety checks, it may lead to larger studies for heart failure tre…

This study evaluates whether a quick blood test for NT-pro-BNP, done in a doctor's office, can help diagnose heart failure earlier in rural areas where specialists are scarce. The test is given to people over 60 with symptoms like shortness of breath or swelling. Researchers will…

This study will test whether an algorithm that analyzes data from Withings smart scales (weight, body water, and step counts) can accurately detect heart failure. Researchers will look back at data from 9,000 people aged 45 and older in the US. If the algorithm works well, it cou…

This study evaluates a simple questionnaire designed to detect decompensated heart failure—a sudden worsening of heart failure—in people aged 55 and older on Réunion Island. Researchers will compare the questionnaire's results with standard heart exams (echocardiogram, ECG, and c…

This pilot study will test whether an AI-assisted ultrasound device can help emergency doctors quickly detect heart failure in patients with symptoms. About 84 adults visiting the ER with signs of heart failure will be enrolled. The goal is to see if this approach is practical an…

This study will enroll 5000 adults to see if a one-minute, single-lead ECG, analyzed by machine learning, can detect heart conditions like high blood pressure, heart failure, and diabetes. Participants will have their ECG recorded twice and compared with full medical exams. The g…

This study will test a rapid finger-prick blood test for heart failure in 618 people with leg swelling (lymphoedema) who have not been diagnosed with heart failure. The test measures a substance called NT-proBNP and gives results in 12 minutes, compared to the usual lab test that…

This study explores whether general practitioners can use a tiny ultrasound device to detect early signs of heart disease during a routine office visit. Researchers will enroll 300 adults aged 65 and older with risk factors, or adults with symptoms like shortness of breath or leg…

This study tests whether a new risk algorithm (FIND HF) can better detect undiagnosed heart failure in people at risk. About 475 adults aged 40+ will have a blood test and heart ultrasound. Researchers will compare how many high-risk vs low-risk people are found to have heart pro…

This study looks at whether a quick, painless liver scan (FibroScan) can accurately detect high central venous pressure in people with heart failure. Currently, doctors use a catheter inserted into the heart to measure this pressure, which carries risks. The study will enroll 149…

This study checks if a new test kit (NTproBNP2) works as well as an existing approved test for measuring a substance linked to heart failure. Researchers will compare results from 120 blood samples of people with or suspected of having heart failure. The goal is to confirm the ne…

This trial tests whether offering a seasonal flu vaccine to heart patients while they are still in the hospital, along with active counseling, increases vaccination rates compared to counseling alone. The study enrolls adults hospitalized for acute coronary syndrome or heart fail…

This study tests if giving a short course of steroids (methylprednisolone) for 7 days can help adults with heart failure who are in cardiogenic shock, a serious condition where the heart can't pump enough blood. The goal is to reduce harmful inflammation and help patients recover…

This trial tests whether slow-paced breathing—reducing breaths to 4-7 per minute—can improve heart rate variability, a marker of heart health, in hospitalized heart failure patients. Participants will be randomly assigned to either standard cardiac rehab alone or rehab plus slow-…

This study tests whether a mobile health program can help people with heart failure increase their physical activity and stay active. The program includes a smartphone app for goal-setting and self-monitoring, an AI-based health coach trained in motivational interviewing, and occ…

Many Veterans with heart failure or COPD struggle with breathlessness, fatigue, depression, and anxiety that routine care often misses. This study tests whether a virtual team—a nurse and a social worker—can improve quality of life by helping Veterans manage their most bothersome…

This study tests a mobile mindfulness program called Lift for people who survived a serious illness in the ICU and now struggle with depression, anxiety, or stress. About 450 adults will use either the Lift app or a health education app for 6 months. The goal is to see if the min…

This study tests a new type of breathing muscle training for people with heart failure. 108 participants will either do the new breathing exercise, a standard one, or usual care for 8 weeks. Researchers will measure if it improves exercise capacity, breathing strength, and qualit…

This study compares two types of exercise—moderate-intensity aerobic training and high-intensity interval training (HIIT)—in women aged 40-70 with stable heart failure. Over 12 weeks, researchers measure how each program affects functional capacity (e.g., walking distance) and qu…

This study tests whether a 6-month digital education program—with short videos on exercise, healthy eating, and stress management—can improve exercise capacity and quality of life in adults with heart failure and overweight or obesity. Fifty-two participants will be randomly assi…

This study tests two types of exercise—aerobic and resistance—both combined with blood flow restriction (using cuffs on the legs) in 40 people with stable heart failure. The goal is to see which approach better improves muscle oxygen levels, heart stress markers, daily function, …

This study tests whether a high-flow nasal cannula (a device that delivers warm, moist air through the nose) can help people with heart failure exercise longer during cardiac rehab. Twenty-eight adults will do two treadmill tests—one with the device and one without—to compare end…

This study tests whether a 12-week home exercise program, guided by a mobile app and smartwatch, can improve exercise capacity and quality of life in people with a left ventricular assist device (LVAD). About 78 participants who recently got an LVAD and cannot attend hospital reh…

This study tests whether an 8-week home telerehabilitation program, with real-time coaching and vital sign monitoring, can improve physical function and reduce frailty in older adults with heart failure. Seventy participants will be randomly assigned to either the telerehab progr…

This study compares two supervised exercise programs—neuromuscular training (focusing on balance and coordination) and resistance training (using weights and bands)—in 40 adults with chronic heart failure. Over 10 weeks, researchers will measure how far participants can walk, the…

This study tests whether a guided breathing technique called heart rate variability biofeedback (HRVB) can reduce anxiety in 60 adults who are in the ICU waiting for a heart transplant. Participants will use a biofeedback device or app during a single session led by a trained cli…

This study is testing whether a mobile app can help people with heart failure take better care of themselves after leaving the hospital. The app provides educational tips, symptom tracking, and ways to communicate with the care team. Thirty participants will use the app alongside…

This study looks at whether adding sauna therapy to standard cardiac rehabilitation can help people with heart failure feel less congested and possibly lower their dose of water pills (diuretics). About 46 adults with heart failure and reduced pumping ability will be randomly ass…

This study will test a cardiac rehabilitation program designed for people over 65 with heart failure. Participants will attend supervised exercise and education sessions twice a week for three months, starting while still in the hospital. The goal is to see if the program improve…

This study tests whether a home-based cardiac rehabilitation program can improve quality of life and health behaviors in heart patients living in low-resource settings in Pakistan. The program includes diet advice, exercise suggestions, medication reminders, and counseling, deliv…

This study tests whether a new type of home oxygen therapy, called high-flow nasal cannula (HFNC), can improve breathing comfort and quality of life for people with long-term lung or heart conditions. Participants will try both HFNC and standard oxygen therapy for two weeks each …

This study tests a personalized system that uses a mobile app and smart wristband to encourage physical activity in 82 adults with heart failure. Participants get custom activity goals, real-time feedback, and motivational support over 12 months. The goal is to see if this approa…

This trial tests whether a medical artificial intelligence (AI) tool can assist primary care doctors in managing chronic conditions like heart disease, atrial fibrillation, heart failure, and stroke. Doctors in the intervention group use the AI to help make decisions about assess…

This study looks at how the stiffness and function of blood vessels change in people newly diagnosed with heart failure. Researchers will measure these factors at the start, after a few weeks of standard medication, and after a cardiac rehab program. All tests are non-invasive an…

This study gathers data from 392 adults with heart failure who need a right heart catheterization. Researchers will use the data to train a machine learning model for a non-invasive device that estimates heart pressure. The goal is to help doctors monitor and treat heart failure …

This study follows 25,000 people referred to a specialized heart clinic with symptoms like chest pain or shortness of breath. Researchers will track which heart conditions are actually diagnosed and how patients are evaluated. The goal is to improve diagnostic accuracy and unders…

This study tests a new home monitoring system called AVATAR-SC that uses a digital avatar to collect voice recordings and symptom questionnaires from heart failure patients. The goal is to see if changes in voice can serve as early warning signs of worsening heart failure. Sixty …

This study checks whether an Apple Watch Series 9 can accurately measure key health indicators—like oxygen levels and exercise capacity—in adults with heart conditions such as congenital heart disease, heart failure, or coronary artery disease. Participants wear the smartwatch du…

This study will look at medical records from over 2 million adults who had surgery in Sweden between 2021 and 2024. Researchers want to see how common heart failure is in surgical patients and whether it raises the risk of death or other problems after surgery. The goal is to bet…

This study looks at whether placing patients face-down (prone) soon after heart surgery can improve how well the right side of the heart works. The idea is that this position helps open up collapsed parts of the lungs, making it easier for the heart to pump blood. About 80 adults…

This study will enroll 1000 heart failure patients to see if different types of body fat—around the heart, under the skin, and within muscles—are linked to heart structure and future health events like heart attacks or strokes. Researchers will use CT scans to measure these fat d…

This study checks if two Italian questionnaires accurately measure how well people with heart failure care for themselves and how caregivers help. Researchers will enroll 1,000 patients and their caregivers across Italy. The goal is to improve heart failure management by using re…

This study looks at whether a new province-wide electronic health record system (called Connect Care) improves outcomes for adults with chronic diseases like diabetes, heart failure, or kidney disease. Researchers will compare hospital readmission and death rates before and after…

This study looks at 223 adults hospitalized with acute heart failure to see if changes in urine salt levels (sodium and chloride) can help doctors understand how well the body is getting rid of extra fluid. Participants will have blood and urine tests, heart ultrasounds, and chec…

This study tests a new, non-invasive device called ODIN that measures how well oxygen is being used in the tiny blood vessels of patients with advanced heart failure or cardiogenic shock in the ICU. About 30 adults will have their oxygen measurements taken with the device and com…

This study will follow up to 840 people with heart disease or COPD who join a group rehab program. Researchers want to see how many patients take part, how often they attend, and how their test results and quality of life change. The goal is to find out what helps patients improv…

This study will follow 200 people with suspected or confirmed cardiac amyloidosis, a condition where abnormal proteins build up in the heart and cause heart failure. Over two years, participants will undergo heart MRI scans, exercise tests, and blood work at regular visits. The g…

This observational study in Mexico will follow 30 adults already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans of the knees, CT scans of the heart, and body composition tests to see how the drug affects cartilage, heart fat, and overal…

This study will follow 2000 adults hospitalized with acute heart failure in Brazil to learn how they are treated and what happens to them over the next year. Researchers want to see if doctors are using the latest recommended medicines and find out what barriers prevent better ca…

This study tests whether giving people with heart or lung conditions real-time air pollution data helps them exercise outdoors more safely. 80 participants will use a smartphone platform that tracks their walking and local air quality. The goal is to see if this approach reduces …

This study tests a simple idea: showing heart failure patients easy-to-understand pictures of how their medications can help them live longer and stay out of the hospital. About 100 adults with heart failure will receive these visual aids along with their usual care. Researchers …

This study will check how well heart failure and atrial fibrillation patients take their medicines after being admitted to the coronary care unit. Researchers will interview 250 adults to understand their medication beliefs and whether their prescriptions are appropriate. The goa…

This study will observe 253 adults with heart rhythm problems who are scheduled for procedures like pacemakers or ablation. Researchers will use advanced imaging and AI tools to understand why some patients respond well to treatment while others do not. The goal is to find better…

This study monitors heart rate variability in 150 adults with type 2 diabetes who also have heart failure, chronic kidney disease, or both. Participants will wear a 24-hour heart monitor before and after starting a standard SGLT2 inhibitor medication. The goal is to understand ho…

This study looks at whether a remote monitoring model called RAPHAEL can work for people with heart failure who may need palliative care. About 90 adults will use a digital questionnaire for 4 weeks to report symptoms and needs, while their healthcare team reviews the results. Th…

This study looks at 200 adults with a type of heart failure called HFpEF. Researchers will use medical records and exercise tests to find different patient groups, or phenotypes. The goal is to better understand these groups, not to test any new treatment. Participants will have …

This study will observe 3,000 adults in China with a type of heart failure called HFpEF who are starting the drug Jardiance. Researchers will track how many patients are hospitalized for heart failure or die from heart-related causes over time. The goal is to see how effective an…

This study will follow 3000 adults with chronic heart failure to see how often they also have kidney disease, diabetes, fatty liver, or clogged arteries. Researchers want to understand how these conditions interact and affect patient outcomes over two years. No new treatments are…

This study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…

This observational study will enroll 112 adults hospitalized for heart failure with preserved or mildly reduced ejection fraction. Researchers will collect blood and urine samples to measure inflammatory biomarkers and analyze genetic factors. The goal is to identify markers that…

This study looks at whether certain blood markers can predict delirium (sudden confusion) in older adults with heart failure. Researchers will compare two markers: one for inflammation (SII) and one for blood sugar and fat levels (TyG). They aim to find a simple way to identify h…

This study will measure a specific heart function index in 2,640 healthy adults and people with heart conditions using AI-enhanced 3D ultrasound. The goal is to establish normal ranges and see how this measurement changes in diseases like heart failure and high blood pressure in …

This study looks at 300 adults hospitalized with heart failure to see if iron deficiency (with or without anemia) is linked to abnormal heart rhythms or ECG changes. Researchers will measure iron levels and monitor for arrhythmias like atrial fibrillation or ventricular tachycard…

This study tests a computer tool that helps doctors and cancer survivors decide together on the best heart-protective medications and tests. Researchers will enroll 60 cancer survivors at risk for heart problems. The goal is to see if the tool is easy to use and helps people foll…

This study will check if three heart failure risk models (MAGGIC, GWTG-HF, and SHFM) accurately predict outcomes like death and hospital readmission in 140 Egyptian patients. These models were developed using mostly Western patients, so they may not work well for Egyptians, who t…

This study will use echocardiography (ultrasound of the heart) to look at how common and how severe diastolic dysfunction—a type of heart stiffness—is in 100 adults with end-stage kidney disease who are on regular hemodialysis. Researchers will also check if certain clinical fact…

This study aims to better understand heart failure by deeply analyzing the genes, proteins, and other molecules in patients' blood and tissues. Researchers will enroll 500 adults with heart failure and combine detailed clinical data with advanced lab tests. The goal is to find mo…

This study looks at whether a hybrid care model—using telemonitoring, teleconsultations, and online tools—can help patients with type 2 diabetes or chronic heart failure get regular care during health emergencies like pandemics. Researchers will follow 180 patients for one year, …